1Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science and.
2the Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom; and.
Am J Respir Cell Mol Biol. 2019 Aug;61(2):232-243. doi: 10.1165/rcmb.2018-0182OC.
Platelets are recruited to inflammatory foci and contribute to host defense and inflammatory responses. Compared with platelet recruitment in hemostasis and thrombosis, the mechanisms of platelet recruitment in inflammation and host defense are poorly understood. Neutrophil recruitment to lung airspaces after inhalation of bacterial LPS requires platelets and PSGL-1 in mice. Given this association between platelets and neutrophils, we investigated whether recruitment of platelets to lungs of mice after LPS inhalation was dependent on PSGL-1, P-selectin, or interaction with neutrophils. BALB/c mice were administered intranasal LPS (O55:B5, 5 mg/kg) and, 48 hours later, lungs were collected and platelets and neutrophils quantified in tissue sections by immunohistochemistry. The effects of functional blocking antibody treatments targeting the platelet-neutrophil adhesion molecules, P-selectin or PSGL-1, or treatment with a neutrophil-depleting antibody targeting Ly6G, were tested on the extent of LPS-induced lung platelet recruitment. Separately in Pf4-Cre × mTmG mice, two-photon intravital microscopy was used to image platelet adhesion in live lungs. Inhalation of LPS caused both platelet and neutrophil recruitment to the lung vasculature. However, decreasing lung neutrophil recruitment by blocking PSGL-1, P-selectin, or depleting blood neutrophils had no effect on lung platelet recruitment. Lung intravital imaging revealed increased adhesion of platelets in the lung microvasculature which was not associated with thrombus formation. In conclusion, platelet recruitment to lungs in response to LPS occurs through mechanisms distinct from those mediating neutrophil recruitment, or the occurrence of pulmonary emboli.
血小板被募集到炎症部位,并有助于宿主防御和炎症反应。与止血和血栓形成中的血小板募集相比,炎症和宿主防御中血小板募集的机制还了解甚少。在吸入细菌 LPS 后,中性粒细胞被募集到肺气道中需要血小板和 PSGL-1 的参与。鉴于血小板与中性粒细胞之间的这种关联,我们研究了 LPS 吸入后血小板向小鼠肺部的募集是否依赖于 PSGL-1、P 选择素或与中性粒细胞的相互作用。给 BALB/c 小鼠鼻内给予 LPS(O55:B5,5mg/kg),48 小时后收集肺部,并通过免疫组织化学在组织切片中定量血小板和中性粒细胞。针对血小板-中性粒细胞黏附分子 P 选择素或 PSGL-1 的功能阻断抗体治疗,或针对 Ly6G 的中性粒细胞耗竭抗体治疗对 LPS 诱导的肺血小板募集的影响进行了测试。分别在 Pf4-Cre × mTmG 小鼠中,使用双光子活体显微镜来成像活肺中的血小板黏附。LPS 的吸入导致血小板和中性粒细胞都募集到肺部血管中。然而,通过阻断 PSGL-1、P 选择素或耗尽血液中的中性粒细胞来减少肺部中性粒细胞的募集,对肺部血小板的募集没有影响。肺部活体成像显示,血小板在肺部微血管中的黏附增加,这与血栓形成无关。总之,LPS 引起的肺部血小板募集是通过与介导中性粒细胞募集或发生肺栓塞不同的机制发生的。